Influence of HLA-DRB1 alleles on antibody responses to PfCP-2.9-immunized and naturally infected individuals

Journal of Clinical Immunology

Volumn 29, Issue 4, 2009, Pages 454-460

  Zhang, Qingfeng ^a,b   Xue, Xiangyang ^b   Xu, Xindong ^b   Wang, Cuiping ^b   Chang, Wenjun ^a   Pan, Weiqing ^a,b  

^a FUDAN UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

HLA DRB1 alleles; malaria vaccine; PfCP 2.9 chimeric protein; Plasmodium falciparum

Indexed keywords

ANTIBODY; HLA DR1 ANTIGEN; HLA DR7 ANTIGEN; MALARIA VACCINE; PLACEBO; PLASMODIUM FALCIPARUM CHIMERIC PROTEIN 2.9; PROTOZOAL PROTEIN; RECOMBINANT APICAL MEMBRANE ANTIGEN 1; RECOMBINANT MEROZOITE SURFACE PROTEIN 1 19; UNCLASSIFIED DRUG;

ADULT; ALLELE; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CELL PROLIFERATION; CHINA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE SEQUENCE; GENOTYPE; HUMAN; IMMUNE RESPONSE; IMMUNITY; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; PARASITEMIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE;

ALLELES; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIBODY FORMATION; ANTIGENS, PROTOZOAN; CLINICAL TRIALS, PHASE I AS TOPIC; GENOTYPE; HLA-DR ANTIGENS; HUMANS; MALARIA VACCINES; MALARIA, FALCIPARUM; MEMBRANE PROTEINS; MEROZOITE SURFACE PROTEIN 1; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VACCINES, SYNTHETIC;

EID: 67651247132     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-009-9281-0     Document Type: Article

References (23)

1. RW Snow CA Guerra AM Noor HY Myint SI Hay 2005 The global distribution of clinical episodes of Plasmodium falciparum malaria Nature 434 214 217 (Pubitemid 40388051)
2. MF Good DC Kaslow LH Miller 1998 Pathways and strategies for developing a malaria blood-stage vaccine Annu Rev Immunol 16 57 87 (Pubitemid 28183359)
3. JA Stoute J Gombe MR Withers J Siangla D McKinney M Onyango 2007 Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya Vaccine 25 176 184 (Pubitemid 44855235)
4. A Dicko I Sagara RD Ellis K Miura O Guindo B Kamate 2008 Phase 1 study of a combination AMA1 blood stage malaria vaccine in Malian children PLoS One 3 e1563
5. K Kato DC Mayer S Singh M Reid LH Miller 2005 Domain III of Plasmodium falciparum apical membrane antigen 1 binds to the erythrocyte membrane protein Kx Proc Natl Acad Sci USA 102 5552 5557 (Pubitemid 40530295)
6. RA O'Donnell TF de Koning-Ward RA Burt M Bockarie JC Reeder AF Cowman 2001 Antibodies against merozoite surface protein (MSP)-1(19) are a major component of the invasion-inhibitory response in individuals immune to malaria J Exp Med 193 1403 1412 (Pubitemid 32565969)
7. AF Egan J Morris G Barnish S Allen BM Greenwood DC Kaslow 1996 Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1 J Infect Dis 173 765 769 (Pubitemid 26069671)
8. EE Murhandarwati CG Black L Wang S Weisman TF Koning-Ward JK Baird 2008 Acquisition of invasion-inhibitory antibodies specific for the 19-kDa fragment of merozoite surface protein 1 in a transmigrant population requires multiple infections J Infect Dis 198 1212 1218
9. W Pan D Huang Q Zhang L Qu D Zhang X Zhang 2004 Fusion of two malaria vaccine candidate antigens enhances product yield, immunogenicity, and antibody-mediated inhibition of parasite growth in vitro J Immunol 172 6167 6174 (Pubitemid 38621222)
10. Q Zhang X Xue L Qu W Pan 2007 Construction and evaluation of a multistage combination vaccine against malaria Vaccine 25 2112 2119 (Pubitemid 46227666)
11. J Hu Z Chen J Gu M Wan Q Shen MP Kieny 2008 Safety and immunogenicity of a malaria vaccine, Plasmodium falciparum AMA-1/MSP-1 chimeric protein formulated in montanide ISA 720 in healthy adults PLoS ONE 3 e1952
12. Germain RN. Antigen processing and presentation, in fundamental immunology. Philadelphia, PA: Lippincott-Raven; 1999. p. 287-340.
13. BJ McFarland C Beeson 2002 Binding interactions between peptides and proteins of the class II major histocompatibility complex Med Res Rev 22 168 203 (Pubitemid 34160584)
14. A Johnson R Leke L Harun C Ginsberg J Ngogang A Stowers 2000 Interaction of HLA and age on levels of antibody to Plasmodium falciparum rhoptry-associated proteins 1 and 2 Infect Immun 68 2231 2236 (Pubitemid 30164859)
15. DM Banic 2004 HLA class II and antibody responses to circumsporozoite protein repeats of P. vivax (VK210, VK247 and P. vivax-like) in individuals naturally exposed to malaria Acta Trop 92 1 63 69 (Pubitemid 39044600)
16. AH Johnson RG Leke NR Mendell D Shon YJ Suh D Bomba-Nkolo 2004 Human leukocyte antigen class II alleles influence levels of antibodies to the Plasmodium falciparum asexual-stage apical membrane antigen 1 but not to merozoite surface antigen 2 and merozoite surface protein 1 Infect Immun 72 2762 2771 (Pubitemid 38542404)
17. G Cifuentes LM Salazar LE Vargas CA Parra M Vanegas J Cortes 2005 Evidence supporting the hypothesis that specifically modifying a malaria peptide to fit into HLA-DRbeta1*03 molecules induces antibody production and protection Vaccine 23 1579 1587 (Pubitemid 40203395)
18. Sambrook J, Fitsch EF, Maniatis T. Molecular cloning: a laboratory manual. New York: Cold Spring Harbor Laboratory; 1989.
19. Bignon JD, Fernández-Viña M, Arnaiz-Villena A, Fauchet R, Weiss E, Powis S, et al. Technical handbook of twelfth international histocompatibility workshop. Paris: HLA et Medicine; 1996.
20. GM Schreuder CK Hurley SG Marsh M Lau MA Fernandez-Vina HJ Noreen 2005 HLA dictionary 2004: summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens Hum Immunol 66 170 210 (Pubitemid 40208205)
21. J Oliveira-Ferreira LR Pratt-Riccio M Arruda F Santos CT Ribeiro AC Goldberg 2004 HLA class II and antibody responses to circumsporozoite protein repeats of P. vivax (VK210, VK247 and P. vivax-like) in individuals naturally exposed to malaria Acta Trop 92 63 69 (Pubitemid 39044600)
22. SL Avila AC Goldberg VG Arruk ML Marin L Guilherme J Kalil 2001 Immune responses to multiple antigen peptides containing T and B epitopes from Plasmodium falciparum circumsporozoite protein of Brazilian individuals naturally exposed to malaria Parasite Immunol 23 103 108 (Pubitemid 32231912)
23. AH Johnson RG Leke NR Mendell D Shon YJ Suh D Bomba-Nkolo 2004 Human leukocyte antigen class II alleles influence levels of antibodies to the Plasmodium falciparum asexual-stage apical membrane antigen 1 but not to merozoite surface antigen 2 and merozoite surface protein 1 Infect Immun 72 2762 2771 (Pubitemid 38542404)